Australia markets closed

Actinogen Medical Limited (ACW.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0260-0.0010 (-3.70%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 68.23M
Enterprise value 56.80M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.70
Enterprise value/revenue N/A
Enterprise value/EBITDA -9.95

Trading information

Stock price history

Beta (5Y monthly) 2.23
52-week change 3-45.94%
S&P500 52-week change 329.31%
52-week high 30.0560
52-week low 30.0150
50-day moving average 30.0303
200-day moving average 30.0260

Share statistics

Avg vol (3-month) 32.14M
Avg vol (10-day) 32.35M
Shares outstanding 52.53B
Implied shares outstanding 62.53B
Float 81.76B
% held by insiders 115.48%
% held by institutions 19.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 303 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,281.93%

Management effectiveness

Return on assets (ttm)-59.24%
Return on equity (ttm)-106.02%

Income statement

Revenue (ttm)4.79M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-9.50%
Gross profit (ttm)N/A
EBITDA -14.82M
Net income avi to common (ttm)-14.87M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.47M
Total cash per share (mrq)0
Total debt (mrq)44.63k
Total debt/equity (mrq)0.37%
Current ratio (mrq)5.42
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-12.53M
Levered free cash flow (ttm)-7.09M